Monday, October 5, 2015

Global Fibromyalgia Pipeline Review 2015 - 6 Companies & 10 Drug Profiles

. Buy Diet Tea online Prograf (Tacrolimus) DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/6pc7nl/fibromyalgia) has announced the addition of the "Fibromyalgia - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Fibromyalgia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. http://medical-reviews.blogspot.com Fucithalmic with free prescription Bactrim (Trimethoprim And Sulfamethoxazole) with free Rx It also reviews key players involved in the therapeutic development for Fibromyalgia and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. About Geriforte () with free Rx Vermox (Mebendazole) without prescription It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development Daiichi Sankyo Company, Limited Intellipharmaceutics International Inc. Merck & Co., Inc. SWITCH Biotech LLC Tonix Pharmaceuticals Holding Corp. Zynerba Pharmaceuticals, Inc. Drug Profiles mirogabalin besylate mirtazapine ODT naltrexone hydrochloride Peptide to Block Voltage-Dependent N-Type Calcium Channel for Cancer Pain and Fibromyalgia pregabalin XR Small Molecules for Fibromyalgia SWT-06101 TD-9855 TNX-102 ZYN-001 For more information visit .researchandmarkets.com/research/6pc7nl/fibromyalgia

No comments:

Post a Comment